{"id":"https://openalex.org/W2128631476","doi":"https://doi.org/10.1182/asheducation-2011.1.96","title":"Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia","display_name":"Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia","alternate_titles":[],"publication_year":2011,"publication_date":"2011-12-07","ids":{"openalex":"https://openalex.org/W2128631476","doi":"https://doi.org/10.1182/asheducation-2011.1.96","mag":"2128631476","pmid":"https://pubmed.ncbi.nlm.nih.gov/22160019"},"language":"en","primary_location":{"id":"doi:10.1182/asheducation-2011.1.96","doi":"https://doi.org/10.1182/asheducation-2011.1.96","is_oa":false,"landing_page_url":"https://doi.org/10.1182/asheducation-2011.1.96","pdf_url":null,"source":{"id":"https://openalex.org/S4210206817","display_name":"Hematology","issn_l":"1520-4383","issn":["1520-4383","1520-4391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320264","host_organization_name":"American Society of Hematology","host_organization_lineage":["https://openalex.org/P4310320264"],"host_organization_lineage_names":["American Society of Hematology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2128631476"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058755419","display_name":"Jan A. Burger","orcid":"https://orcid.org/0000-0002-6177-7572","observed_orcids":["https://orcid.org/0000-0002-6177-7572"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jan A. Burger","raw_affiliation_strings":["Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5058755419"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":null,"apc_paid":null,"fwci":3.3097,"has_fulltext":false,"cited_by_count":236,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.95374912,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"2011","issue":"1","first_page":"96","last_page":"103"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":1.0},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9769999980926514},{"id":"https://openalex.org/keywords/cxcr4-antagonist","display_name":"CXCR4 antagonist","score":0.9729999899864197},{"id":"https://openalex.org/keywords/syk","display_name":"Syk","score":0.8519999980926514},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase","display_name":"Bruton's tyrosine kinase","score":0.9860000014305115},{"id":"https://openalex.org/keywords/pi3kdelta-inhibitor","display_name":"PI3K\u03b4 inhibitor","score":0.9480000138282776},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.843999981880188},{"id":"https://openalex.org/keywords/in-vitro-and-in-vivo-models","display_name":"in vitro and in vivo models","score":0.6740000247955322},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.6349999904632568},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.6359999775886536}],"concepts":[{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.8218608498573303},{"id":"https://openalex.org/C35174551","wikidata":"https://www.wikidata.org/wiki/Q7660502","display_name":"Syk","level":4,"score":0.8172355890274048},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.7182559967041016},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6515317559242249},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.6107210516929626},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6095134615898132},{"id":"https://openalex.org/C43907098","wikidata":"https://www.wikidata.org/wiki/Q903924","display_name":"breakpoint cluster region","level":3,"score":0.48443058133125305},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4747393727302551},{"id":"https://openalex.org/C129470790","wikidata":"https://www.wikidata.org/wiki/Q415718","display_name":"CXCR4","level":4,"score":0.47372475266456604},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4285741150379181},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40190306305885315},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3980695903301239},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2722975015640259},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.17539280652999878},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1329890787601471},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.09675377607345581},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09516486525535583},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.0},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D004777","descriptor_name":"Environment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1182/asheducation-2011.1.96","doi":"https://doi.org/10.1182/asheducation-2011.1.96","is_oa":false,"landing_page_url":"https://doi.org/10.1182/asheducation-2011.1.96","pdf_url":null,"source":{"id":"https://openalex.org/S4210206817","display_name":"Hematology","issn_l":"1520-4383","issn":["1520-4383","1520-4391"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320264","host_organization_name":"American Society of Hematology","host_organization_lineage":["https://openalex.org/P4310320264"],"host_organization_lineage_names":["American Society of Hematology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology","raw_type":"journal-article"},{"id":"pmid:22160019","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22160019","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology. American Society of Hematology. Education Program","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000878657","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320308594","display_name":"CLL Global Research Foundation","ror":"https://ror.org/0472hmc50"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":64,"referenced_works":["https://openalex.org/W34261213","https://openalex.org/W76370582","https://openalex.org/W115619992","https://openalex.org/W899734449","https://openalex.org/W1492263161","https://openalex.org/W1531083786","https://openalex.org/W1964899672","https://openalex.org/W1969487650","https://openalex.org/W1971436806","https://openalex.org/W1971487921","https://openalex.org/W1972593274","https://openalex.org/W1973379466","https://openalex.org/W1976088592","https://openalex.org/W1976402300","https://openalex.org/W1976767301","https://openalex.org/W1982822355","https://openalex.org/W1990159135","https://openalex.org/W1991988527","https://openalex.org/W1993598575","https://openalex.org/W1993986769","https://openalex.org/W1995629680","https://openalex.org/W2004264801","https://openalex.org/W2005150159","https://openalex.org/W2007973857","https://openalex.org/W2009593167","https://openalex.org/W2010811029","https://openalex.org/W2018531061","https://openalex.org/W2019655196","https://openalex.org/W2026234361","https://openalex.org/W2027971058","https://openalex.org/W2033315156","https://openalex.org/W2035916624","https://openalex.org/W2046304104","https://openalex.org/W2070014828","https://openalex.org/W2072810750","https://openalex.org/W2075510715","https://openalex.org/W2075875145","https://openalex.org/W2076690627","https://openalex.org/W2080737275","https://openalex.org/W2083420319","https://openalex.org/W2086423745","https://openalex.org/W2090358449","https://openalex.org/W2091961397","https://openalex.org/W2093538016","https://openalex.org/W2098651795","https://openalex.org/W2099348990","https://openalex.org/W2108131308","https://openalex.org/W2119374469","https://openalex.org/W2122681203","https://openalex.org/W2124133381","https://openalex.org/W2143790526","https://openalex.org/W2145132518","https://openalex.org/W2149888039","https://openalex.org/W2154992334","https://openalex.org/W2156834005","https://openalex.org/W2158313081","https://openalex.org/W2158509187","https://openalex.org/W2163690533","https://openalex.org/W2242208648","https://openalex.org/W2515768560","https://openalex.org/W2563249086","https://openalex.org/W2565891762","https://openalex.org/W2584629017","https://openalex.org/W4313377143"],"related_works":["https://openalex.org/W2507575462","https://openalex.org/W101553012","https://openalex.org/W2024489920","https://openalex.org/W2023418231","https://openalex.org/W2183229102","https://openalex.org/W2100707945","https://openalex.org/W1982769358","https://openalex.org/W3195083678","https://openalex.org/W2185820237","https://openalex.org/W2480639287"],"abstract_inverted_index":{"Intrinsic":[0],"factors":[1],"such":[2],"as":[3],"genetic":[4],"lesions,":[5],"anti-apoptotic":[6],"proteins,":[7],"and":[8,51,63,73,81,101,108,125,139,143,166,170],"aberrant":[9],"signaling":[10],"networks":[11],"within":[12],"leukemia":[13,24,41],"cells":[14,138],"have":[15],"long":[16],"been":[17],"the":[18,29,40,65,87,128,140],"main":[19],"focus":[20],"of":[21,76,111],"chronic":[22],"lymphocytic":[23],"(CLL)":[25],"research.":[26],"However,":[27],"over":[28],"past":[30],"decade,":[31],"it":[32],"became":[33],"increasingly":[34],"clear":[35],"that":[36,148,162],"external":[37],"signals":[38],"from":[39,155],"microenvironment":[42,89],"make":[43],"pivotal":[44],"contributions":[45],"to":[46],"disease":[47,173],"progression":[48,174],"in":[49,82,96,102,175],"CLL":[50,66,88,137,150],"other":[52],"B-cell":[53],"malignancies.":[54],"Consequently,":[55],"increasing":[56],"emphasis":[57],"is":[58],"now":[59],"placed":[60],"on":[61],"exploring":[62],"targeting":[64,133],"microenvironment.":[67],"This":[68],"review":[69],"highlights":[70],"critical":[71],"cellular":[72],"molecular":[74],"pathways":[75],"CLL-microenvironment":[77],"cross-talk.":[78],"In":[79],"vitro":[80],"vivo":[83],"models":[84],"for":[85,98,132],"studying":[86],"are":[90,127],"discussed,":[91],"along":[92],"with":[93],"their":[94],"use":[95],"searching":[97],"therapeutic":[99],"targets":[100],"drug":[103],"testing.":[104],"Clinically,":[105],"CXCR4":[106],"antagonists":[107,110],"small-molecule":[109],"B":[112],"cell":[113],"receptor":[114],"(BCR)-associated":[115],"kinases":[116],"(spleen":[117],"tyrosine":[118,122],"kinase":[119,123],"[Syk],":[120],"Bruton's":[121],"[Btk],":[124],"PI3K\u03b4)":[126],"most":[129],"advanced":[130],"drugs":[131],"specific":[134],"interactions":[135],"between":[136,164],"miocroenvironment.":[141],"Preclinical":[142],"first":[144],"clinical":[145],"evidence":[146],"suggests":[147],"high-risk":[149],"patients":[151],"can":[152],"particularly":[153],"benefit":[154],"these":[156],"alternative":[157],"agents.":[158],"These":[159],"findings":[160],"indicate":[161],"interplay":[163],"leukemia-inherent":[165],"environmental":[167],"factors,":[168],"nature":[169],"nurture":[171],"determines":[172],"CLL.":[176]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2128631476","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":14},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":22},{"year":2017,"cited_by_count":20},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":24},{"year":2014,"cited_by_count":28},{"year":2013,"cited_by_count":41},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
